Abcuro
Terry Chaney is an experienced professional in the field of Quality Assurance and Operations, currently serving as the Associate Director of GMP QA Operations at Abcuro, Inc., since April 2023. Previous positions include Senior Project Manager at Dantari, Inc., and Senior Manager in Supply Chain Operations at ADMA Biologics, where responsibilities encompassed oversight of contract manufacturing organizations (CMOs) and quality systems. Earlier roles include QA Manager at Mallinckrodt Pharmaceuticals and Manager of Clinical Quality Assurance at Gilead Sciences, focusing on quality oversight across multiple manufacturing aspects. Chaney's extensive experience began at Genentech, managing audits and investigations to address product discrepancies. Educational credentials include a Bachelor of Science in Microbiology from Central Washington University, various certifications in quality assurance, and experience as an Aviation Electronics Technician in the US Navy.
This person is not in the org chart
This person is not in any offices
Abcuro
2 followers
Abcuro is a clinical stage biotechnology company developing treatments for autoimmune and cancer indications modulated by cytotoxic T and NK cells that express the inhibitory immune checkpoint receptor KLRG1 (killer cell lectin-like receptor G1). The company is advancing ABC008, a first-in-class anti-KLRG1 antibody designed to deplete cytotoxic T cells that attack healthy muscle tissue in patients with inclusion body myositis (IBM), into clinical studies.